Market Movers: Healthways, K-Swiss, CollaGenex

Healthways Lowering 2008 Forecast on Slower Program Enrollment and Contracts; K-Swiss Plummets as...  More »

Healthways Lowering 2008 Forecast on Slower Program Enrollment and Contracts; K-Swiss Plummets as Forecasts Trail Analysts' Average Estimates; Galderma Agrees to Buy CollaGenex for $420 Million  « Less